Simple Summary CA125 has been the most promising biomarker for screening ovarian
cancer; however, it still does not have an acceptable accuracy in population-based …

Glycosylation of proteins is one of the most important PTMs, with more than half of all human
proteins estimated to be glycosylated. It is widely known that aberrant glycosylation has …

Liquid biopsies hold the potential to inform cancer patient prognosis and to guide treatment
decisions at the time when direct tumor biopsy may be impractical due to its invasive nature …

The standard initial management of epithelial ovarian cancer consists of surgical staging,
operative tumour debulking including total abdominal hysterectomy and bilateral sal**o …

Foreword This Journal feature begins with a case vignette highlighting a common clinical
problem. Evidence supporting various strategies is then presented, followed by a review of …

Biomarkers are vital in healthcare as they provide valuable insights into disease diagnosis,
prognosis, treatment response, and personalized medicine. They serve as objective …

Most clinical blood biomarkers lack the necessary sensitivity and specificity to reliably detect
cancer at an early stage, when it is best treatable. It is not yet clear how early a clinical blood …

Important Notice: The digital edition of this book is missing some of the images or content
found in the physical edition. The gold standard for midwives and students is back with …

CA125 is the gold standard tumor marker in ovarian cancer. Serum level of CA125 is used to
monitor response to chemotherapy, relapse, and disease progression in ovarian cancer …

Background Inflammation plays an important role in the pathogenesis of ovarian cancer.
This study sought to investigate the association between the preoperative c-reactive …